NewGenIvf Group Limited (NIVF)
NIVF trades on Nasdaq in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1981662/000121390026037687/0001213900-26-037687-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | NIVF on Nasdaq |
| Sector | Health Care |
| Industry | Misc Health and Biotechnology Services |
| Country | Singapore |
| IPO year | Not reported by the screener |
| SEC CIK | 0001981662 |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
| Incorporated in | Virgin Islands, British |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $4.7M |
| Net income | $9.9M |
| Operating income | -$10.7M |
| Net margin | 209.0% |
| Operating margin | -226.9% |
| Revenue growth | -13.0% |
| Cash | $759K |
| Total assets | $32.7M |
| P/E (computed) | 0.2× |
| P/S (computed) | 0.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-03-31 |
| Cash and burn | $759K cash; operating cash flow -$2.7M a quarter. | Report 2025-12-31 |
| Shares outstanding | No cover-page share count in XBRL | Cover page 2025-12-31 |
| Reverse splits, 3 years | 9; latest 1-for-8 on 2026-10-23 | Source 2026-10-23 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-10-27 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | J&S Associate PLT, Kuala Lumpur, Malaysia | PCAOB Form AP 2026-10-05 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $527K, sold $119K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $4.7M | $9.9M | -$10.9M | $759K | $519K | $4.7M | 20-F 2026-03-31 |
| FY 2024 2024-12-31 | $5.4M | -$525K | -$8.3M | $458K | $582K | $5.4M | 20-F 2026-03-31 |
| FY 2023 2023-12-31 | $5.1M | $130K | -$1.8M | $54K | No debt tags | $5.1M | 20-F 2026-03-31 |
| FY 2022 2022-12-31 | $5.9M | $459K | $1.7M | $28K | No debt tags | $5.9M | 20-F/A 2025-05-15 |
| FY 2021 2021-12-31 | $4.1M | -$533 | $1.4M | $29K | No debt tags | $4.1M | 20-F 2024-08-20 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | F-3 | 2026-10-27 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-03-31 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-11-16 |
Source: SEC EDGAR submissions feed, 198 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -49.5% |
| 1 month | -85.2% |
| 3 months | -99.6% |
| Year to date | -100.0% |
| 1 year | -100.0% |
| From 52-week high | -100.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| NIVFW | NewGenIvf Group Limited Warrants | $0.0075 |
Peers in Misc Health and Biotechnology Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MGRX | Mangoceuticals Inc. | $0.1603 | +3.42% | $3.6M |
| CCEL | Cryo-Cell International Inc. | $4.55 | -6.19% | $36.7M |
| PARK | Park Dental Partners Inc. | $19.72 | -8.24% | $109.2M |
| VMD | Viemed Healthcare Inc. Common Shares | $9.15 | -0.22% | $346.7M |
| AGL | agilon health inc. | $116.75 | +0.94% | $2.0B |
| PGNY | Progyny Inc. | $37.15 | +2.68% | $2.7B |
| SHC | Sotera Health Company | $16.25 | -2.17% | $4.6B |
| DVA | DaVita Inc. | $174.22 | -0.19% | $11.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier